Chemotactic cytokines recruiting neutrophils (e.g., IL-8) into tumors have been investigated as potential prognostic markers for the effectiveness of cancer drugs targeting inhibitory immune checkpoints (de Andrea et al., 2021; Wang et al., 2021). This evidence concerns the gene CXCL8 and cancer.